OPRK1 and myocardial infarction: For example, it has been demonstrated that U50,488H, a selective agonist of κ-OR, reduces the myocardial infarct size caused by I/R [20,21,22,23], and this effect is reversed by nor-BNI, which is a selective antagonist of κ-OR [22,24,25].